• |
All-time record revenue of $421 million, up 14 percent year over year
|
• |
All-time record orders up 19 percent year over year
|
• |
Strong diluted GAAP EPS of $0.30
|
• |
All-time record diluted non-GAAP EPS of $0.60
|
• |
Cash and cash equivalents of $211 million as of December 31, 2021
|
• |
Returned $66 million to stockholders through stock repurchase and dividends
|
• |
All-time record revenue of $1.47 billion, up 14 percent year over year
|
• |
GAAP gross margin of 71 percent
|
• |
Non-GAAP gross margin of 75 percent
|
• |
Strong diluted GAAP EPS of $0.67
|
• |
Record diluted non-GAAP EPS of $1.68
|
• |
Returned $198 million to stockholders through stock repurchase and dividends
|
• |
GAAP revenue to be in the range of $385 million to $415 million, up 19 percent year over year at the midpoint
|
• |
GAAP diluted EPS to be in the range of $0.13 to $0.27, up 17 cents year over year at the midpoint
|
• |
Non-GAAP diluted EPS expected to be in the range of $0.35 to $0.49, up 31 percent year over year at the midpoint
|
National Instruments
| ||||||||
Condensed Consolidated Balance Sheets
| ||||||||
(in thousands)
| ||||||||
December 31,
|
December 31,
| |||||||
2021
|
2020
| |||||||
(unaudited)
| ||||||||
ASSETS
| ||||||||
Current assets:
| ||||||||
Cash and cash equivalents
|
$
|
211,106
|
$
|
260,232
| ||||
Short-term investments
|
-
|
59,923
| ||||||
Accounts receivable, net
|
341,275
|
266,869
| ||||||
Inventories, net
|
289,243
|
194,012
| ||||||
Prepaid expenses and other current assets
|
90,225
|
68,470
| ||||||
Total current assets
|
931,849
|
849,506
| ||||||
Property and equipment, net
|
253,668
|
254,399
| ||||||
Goodwill
|
583,589
|
467,547
| ||||||
Intangible assets, net
|
212,521
|
172,719
| ||||||
Operating lease right-of-use assets
|
58,641
|
67,674
| ||||||
Other long-term assets
|
74,717
|
72,643
| ||||||
Total assets
|
2,114,985
|
1,884,488
| ||||||
LIABILITIES AND EQUITY
| ||||||||
Current liabilities:
| ||||||||
Accounts payable and accrued liabilities
|
83,218
|
51,124
| ||||||
Accrued compensation
|
111,261
|
87,068
| ||||||
Deferred revenue
|
137,818
|
132,151
| ||||||
Operating lease liabilities
|
13,137
|
15,801
| ||||||
Other taxes payable
|
59,109
|
48,129
| ||||||
Debt - current
|
-
|
5,000
| ||||||
Other current liabilities
|
40,671
|
42,578
| ||||||
Total current liabilities
|
445,214
|
381,851
| ||||||
Debt - non-current
|
300,000
|
92,036
| ||||||
Deferred income taxes
|
14,249
|
25,288
| ||||||
Income tax payable - non-current
|
54,195
|
61,623
| ||||||
Deferred revenue - non-current
|
32,822
|
36,335
| ||||||
Operating lease liabilities - non-current
|
30,468
|
35,854
| ||||||
Other long-term liabilities
|
14,340
|
26,630
| ||||||
Total liabilities
|
891,288
|
659,617
| ||||||
Stockholders' equity:
| ||||||||
Preferred stock
|
-
|
-
| ||||||
Common stock
|
1,323
|
1,312
| ||||||
Additional paid-in capital
|
1,129,647
|
1,033,284
| ||||||
Retained earnings
|
112,858
|
211,101
| ||||||
Accumulated other comprehensive loss
|
(20,131
|
)
|
(20,826
|
)
| ||||
Total stockholders' equity
|
1,223,697
|
1,224,871
| ||||||
Total liabilities and stockholders' equity
|
$
|
2,114,985
|
$
|
1,884,488
|
National Instruments
| ||||||||||||||||
Condensed Consolidated Statements of Income
| ||||||||||||||||
(in thousands, except per share data, unaudited)
| ||||||||||||||||
Three Months Ended
|
Years Ended
| |||||||||||||||
December 31,
|
December 31,
| |||||||||||||||
2021
|
2020
|
2021
|
2020
| |||||||||||||
Net sales:
| ||||||||||||||||
Product
|
$
|
377,303
|
$
|
327,714
|
$
|
1,304,609
|
$
|
1,137,603
| ||||||||
Software maintenance
|
43,338
|
40,124
|
165,072
|
149,068
| ||||||||||||
Total net sales
|
420,641
|
367,838
|
1,469,681
|
1,286,671
| ||||||||||||
Cost of sales:
| ||||||||||||||||
Product
|
119,857
|
105,625
|
406,342
|
359,861
| ||||||||||||
Software maintenance
|
3,739
|
3,571
|
14,621
|
11,260
| ||||||||||||
Total cost of sales
|
123,596
|
109,196
|
420,963
|
371,121
| ||||||||||||
Gross profit
|
297,045
|
258,642
|
1,048,718
|
915,550
| ||||||||||||
71%
|
70%
|
71%
|
71%
| |||||||||||||
Operating expenses:
| ||||||||||||||||
Sales and marketing
|
122,304
|
134,570
|
467,352
|
465,509
| ||||||||||||
Research and development
|
92,301
|
73,733
|
335,986
|
280,381
| ||||||||||||
General and administrative
|
32,543
|
36,883
|
127,215
|
129,863
| ||||||||||||
Total operating expenses
|
247,148
|
245,186
|
930,553
|
875,753
| ||||||||||||
Gain on sale of business
|
-
|
-
|
-
|
159,753
| ||||||||||||
Operating income
|
49,897
|
13,456
|
118,165
|
199,550
| ||||||||||||
Other income (expense)
|
(4,739
|
)
|
1,797
|
(14,590
|
)
|
(788
|
)
| |||||||||
Income before income taxes
|
45,158
|
15,253
|
103,575
|
198,762
| ||||||||||||
Provision for income taxes
|
4,822
|
10,515
|
14,260
|
55,103
| ||||||||||||
Net income
|
$
|
40,336
|
$
|
4,738
|
$
|
89,315
|
$
|
143,659
| ||||||||
Basic earnings per share
|
$
|
0.31
|
$
|
0.04
|
$
|
0.68
|
$
|
1.10
| ||||||||
Diluted earnings per share
|
$
|
0.30
|
$
|
0.04
|
$
|
0.67
|
$
|
1.09
| ||||||||
Weighted average shares outstanding -
| ||||||||||||||||
Basic
|
132,215
|
131,277
|
132,311
|
131,082
| ||||||||||||
Diluted
|
133,225
|
131,732
|
133,562
|
131,799
| ||||||||||||
Dividends declared per share
|
$
|
0.27
|
$
|
0.26
|
$
|
1.08
|
$
|
1.04
|
National Instruments
| ||||||||
Condensed Consolidated Statements of Cash Flows
| ||||||||
(in thousands)
| ||||||||
Years Ended December 31,
| ||||||||
2021
|
2020
| |||||||
(unaudited)
| ||||||||
Cash flow from operating activities:
| ||||||||
Net income
|
$
|
89,315
|
$
|
143,659
| ||||
Adjustments to reconcile net income to net cash provided by operating activities:
| ||||||||
Depreciation and amortization
|
99,402
|
87,064
| ||||||
Stock-based compensation
|
74,583
|
58,376
| ||||||
Disposal gain on sale of business/asset
|
-
|
(159,753
|
)
| |||||
Loss from equity-method investees
|
5,719
|
2,942
| ||||||
Deferred income taxes
|
(15,796
|
)
|
7,771
| |||||
Net change in operating assets and liabilities
|
(110,020
|
)
|
40,708
| |||||
Net cash provided by operating activities
|
143,203
|
180,767
| ||||||
Cash flow from investing activities:
| ||||||||
Acquisitions, net of cash received
|
(222,783
|
)
|
(334,981
|
)
| ||||
Proceeds from sale of assets/business, net of cash divested
|
-
|
160,266
| ||||||
Capital expenditures
|
(40,975
|
)
|
(49,652
|
)
| ||||
Capitalization of internally developed software
|
(1,464
|
)
|
(4,054
|
)
| ||||
Additions to other intangibles
|
(2,751
|
)
|
(1,441
|
)
| ||||
Acquisitions of equity-method and other investments
|
(15,753
|
)
|
(9,761
|
)
| ||||
Purchases of short-term investments
|
-
|
(206,330
|
)
| |||||
Sales and maturities of short-term investments
|
60,297
|
384,652
| ||||||
Net cash used by investing activities
|
(223,429
|
)
|
(61,301
|
)
| ||||
Cash flow from financing activities:
| ||||||||
Proceeds from term loan
|
-
|
170,000
| ||||||
Payments of term loan
|
(98,750
|
)
|
(71,250
|
)
| ||||
Proceeds from revolving line of credit
|
300,000
|
20,000
| ||||||
Payments of revolving line of credit
|
-
|
(20,000
|
)
| |||||
Debt issuance costs
|
(1,993
|
)
|
(1,893
|
)
| ||||
Proceeds from issuance of common stock
|
32,518
|
31,947
| ||||||
Repurchase of common stock
|
(55,000
|
)
|
(48,713
|
)
| ||||
Dividends paid
|
(143,113
|
)
|
(136,545
|
)
| ||||
Net cash provided by (used by) financing activities
|
33,662
|
(56,454
|
)
| |||||
Impact of changes in exchange rates on cash
|
(2,562
|
)
|
2,604
| |||||
Net change in cash and cash equivalents
|
(49,126
|
)
|
65,616
| |||||
Cash and cash equivalents at beginning of period
|
260,232
|
194,616
| ||||||
Cash and cash equivalents at end of period
|
$
|
211,106
|
$
|
260,232
|
Three Months Ended
|
Years Ended
| |||||||||||||||
December 31,
|
December 31,
| |||||||||||||||
2021
|
2020
|
2021
|
2020
| |||||||||||||
Stock-based compensation
| ||||||||||||||||
Cost of sales
|
$
|
1,092
|
$
|
979
|
$
|
4,580
|
$
|
3,766
| ||||||||
Sales and marketing
|
6,284
|
5,462
|
25,233
|
22,288
| ||||||||||||
Research and development
|
5,811
|
5,129
|
23,515
|
17,769
| ||||||||||||
General and administrative
|
5,335
|
4,251
|
21,384
|
14,552
| ||||||||||||
Provision for income taxes
|
(2,010
|
)
|
(445
|
)
|
(12,047
|
)
|
(8,705
|
)
| ||||||||
Total
|
$
|
16,512
|
$
|
15,376
|
$
|
62,665
|
$
|
49,670
| ||||||||
Amortization of acquisition-related intangibles and fair value adjustments
| ||||||||||||||||
Net sales
|
$
|
352
|
$
|
1,961
|
$
|
2,324
|
$
|
3,260
| ||||||||
Cost of sales
|
6,700
|
4,313
|
19,391
|
9,892
| ||||||||||||
Sales and marketing
|
3,334
|
1,965
|
10,192
|
5,264
| ||||||||||||
Research and development
|
320
|
9
|
320
|
94
| ||||||||||||
General and administrative
|
-
|
846
|
-
|
846
| ||||||||||||
Other expense (income)
|
531
|
124
|
2,007
|
487
| ||||||||||||
Provision for income taxes
|
(1,626
|
)
|
(606
|
)
|
(4,071
|
)
|
(2,554
|
)
| ||||||||
Total
|
$
|
9,611
|
$
|
8,612
|
$
|
30,163
|
$
|
17,289
| ||||||||
Acquisition-related transaction and integration costs, restructuring charges, and other(1)(2) | ||||||||||||||||
Cost of sales
|
$
|
25
|
$
|
1,620
|
$
|
(25
|
)
|
$
|
1,626
| |||||||
Sales and marketing
|
1,687
|
23,309
|
7,759
|
32,079
| ||||||||||||
Research and development
|
9,682
|
1,184
|
11,104
|
6,374
| ||||||||||||
General and administrative (1) |
865
|
8,685
|
8,254
|
21,279
| ||||||||||||
Gain on sale of business/asset (2) |
-
|
-
|
-
|
(159,753
|
)
| |||||||||||
Other expense (income)
|
-
|
191
|
4,322
|
589
| ||||||||||||
Provision for income taxes
|
(2,708
|
)
|
(1,602
|
)
|
(6,837
|
)
|
32,364
| |||||||||
Total
|
$
|
9,551
|
$
|
33,387
|
$
|
24,577
|
$
|
(65,442
|
)
| |||||||
(1): During the third quarter of 2020, we recognized $5 million of compensation expense related to the replacement of unvested options acquired from OptimalPlus. These amounts were accounted for as post-combination expense and will be recognized over the required service period
| ||||||||||||||||
(2): During the first quarter of 2020, we recognized a gain of $160 million related to the divestiture of AWR, presented within "Gain on sale of business/assets".
| ||||||||||||||||
(Capitalization) and amortization of internally developed software costs
| ||||||||||||||||
Cost of sales
|
$
|
5,041
|
$
|
6,936
|
$
|
23,674
|
$
|
27,931
| ||||||||
Research and development
|
(188
|
)
|
(1,248
|
)
|
(1,433
|
)
|
(4,043
|
)
| ||||||||
Provision for income taxes
|
(1,085
|
)
|
(1,195
|
)
|
(4,877
|
)
|
(5,017
|
)
| ||||||||
Total
|
$
|
3,768
|
$
|
4,493
|
$
|
17,364
|
$
|
18,871
|
National Instruments
| ||||||||||||||||
Reconciliation of GAAP to Non-GAAP Measures
| ||||||||||||||||
(in thousands, unaudited)
| ||||||||||||||||
Three Months Ended
|
Years Ended
| |||||||||||||||
December 31,
|
December 31,
| |||||||||||||||
2021
|
2020
|
2021
|
2020
| |||||||||||||
Reconciliation of Net sales to Non-GAAP Net sales | ||||||||||||||||
Net sales, as reported
|
$
|
420,641
|
$
|
367,838
|
$
|
1,469,681
|
$
|
1,286,671
| ||||||||
Impact of acquisition related fair value adjustments
|
352
|
1,961
|
2,324
|
3,260
| ||||||||||||
Non-GAAP net sales
|
$
|
420,993
|
$
|
369,799
|
$
|
1,472,005
|
$
|
1,289,931
| ||||||||
Reconciliation of Gross Profit to Non-GAAP Gross Profit | ||||||||||||||||
Gross profit, as reported
|
$
|
297,045
|
$
|
258,642
|
$
|
1,048,718
|
$
|
915,550
| ||||||||
Stock-based compensation
|
1,092
|
979
|
4,580
|
3,766
| ||||||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
7,052
|
6,274
|
21,715
|
13,152
| ||||||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
25
|
1,620
|
(25
|
)
|
1,626
| |||||||||||
Amortization of internally developed software costs
|
5,041
|
6,936
|
23,674
|
27,931
| ||||||||||||
Non-GAAP gross profit
|
$
|
310,255
|
$
|
274,451
|
$
|
1,098,662
|
$
|
962,025
| ||||||||
Non-GAAP gross margin
|
74%
|
74%
|
75%
|
75%
| ||||||||||||
Reconciliation of Operating Expenses to Non-GAAP Operating Expenses | ||||||||||||||||
Operating expenses, as reported
|
$
|
247,148
|
$
|
245,186
|
$
|
930,553
|
$
|
875,753
| ||||||||
Stock-based compensation
|
(17,430
|
)
|
(14,842
|
)
|
(70,132
|
)
|
(54,609
|
)
| ||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
(3,654
|
)
|
(2,820
|
)
|
(10,512
|
)
|
(6,204
|
)
| ||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
(12,234
|
)
|
(33,178
|
)
|
(27,117
|
)
|
(59,732
|
)
| ||||||||
Capitalization of internally developed software costs
|
188
|
1,248
|
1,433
|
4,043
| ||||||||||||
Non-GAAP operating expenses
|
$
|
214,018
|
$
|
195,594
|
$
|
824,225
|
$
|
759,251
| ||||||||
Reconciliation of Operating Income to Non-GAAP Operating Income | ||||||||||||||||
Operating income, as reported
|
$
|
49,897
|
$
|
13,456
|
$
|
118,165
|
$
|
199,550
| ||||||||
Stock-based compensation
|
18,522
|
15,821
|
74,712
|
58,375
| ||||||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
10,706
|
9,094
|
32,227
|
19,356
| ||||||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
12,259
|
34,798
|
27,092
|
61,358
| ||||||||||||
Net amortization of internally developed software costs
|
4,853
|
5,688
|
22,241
|
23,888
| ||||||||||||
Gain on sale of business/assets
|
-
|
-
|
-
|
(159,753
|
)
| |||||||||||
Non-GAAP operating income
|
$
|
96,237
|
$
|
78,857
|
$
|
274,437
|
$
|
202,774
| ||||||||
Non-GAAP operating margin
|
23%
|
21%
|
19%
|
16%
| ||||||||||||
Reconciliation of Provision for income taxes to Non-GAAP Provision for income taxes | ||||||||||||||||
Provision for income taxes, as reported(1) |
$
|
4,822
|
$
|
10,515
|
$
|
14,260
|
$
|
55,103
| ||||||||
Stock-based compensation
|
2,010
|
445
|
12,047
|
8,705
| ||||||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
1,626
|
606
|
4,071
|
2,554
| ||||||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
2,708
|
1,328
|
6,837
|
4,122
| ||||||||||||
Net amortization of internally developed software costs
|
1,085
|
1,195
|
4,877
|
5,017
| ||||||||||||
Gain on sale of business/assets
|
-
|
274
|
-
|
(36,486
|
)
| |||||||||||
Non-GAAP provision for income taxes(1) |
$
|
12,251
|
$
|
14,363
|
$
|
42,092
|
$
|
39,015
| ||||||||
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
|
Reconciliation of GAAP Net Income and Diluted EPS to Non-GAAP Net Income and Non-GAAP Diluted EPS
| ||||||||||||||||
(in thousands, except per share data, unaudited)
| ||||||||||||||||
Three Months Ended
|
Years Ended
| |||||||||||||||
December 31,
|
December 31,
| |||||||||||||||
2021
|
2020
|
2021
|
2020
| |||||||||||||
Net income, as reported
|
$
|
40,336
|
$
|
4,738
|
$
|
89,315
|
$
|
143,659
| ||||||||
Adjustments to reconcile net income to non-GAAP net income:
| ||||||||||||||||
Stock-based compensation
|
18,522
|
15,821
|
74,712
|
58,375
| ||||||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
11,237
|
9,218
|
34,234
|
19,843
| ||||||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
12,259
|
34,989
|
31,414
|
61,947
| ||||||||||||
Net amortization of internally developed software costs
|
4,853
|
5,688
|
22,241
|
23,888
| ||||||||||||
Gain on sale of business/asset
|
-
|
-
|
-
|
(159,753
|
)
| |||||||||||
Income tax effects and adjustments(1) |
(7,429
|
)
|
(3,848
|
)
|
(27,832
|
)
|
16,088
| |||||||||
Non-GAAP net income
|
$
|
79,778
|
$
|
66,606
|
$
|
224,084
|
$
|
164,047
| ||||||||
Non-GAAP net margin
|
18.9%
|
18.0%
|
15.2%
|
12.7%
| ||||||||||||
Diluted EPS, as reported
|
$
|
0.30
|
$
|
0.04
|
$
|
0.67
|
$
|
1.09
| ||||||||
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS
| ||||||||||||||||
Stock-based compensation
|
0.14
|
0.12
|
0.56
|
0.44
| ||||||||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
0.09
|
0.07
|
0.26
|
0.15
| ||||||||||||
Acquisition transaction and integration costs, restructuring charges and other
|
0.09
|
0.27
|
0.23
|
0.47
| ||||||||||||
Net amortization of internally developed software costs
|
0.04
|
0.04
|
0.17
|
0.18
| ||||||||||||
Gain on sale of business/asset
|
-
|
-
|
-
|
(1.21
|
)
| |||||||||||
Income tax effects and adjustments(1) |
(0.06
|
)
|
(0.03
|
)
|
(0.21
|
)
|
0.12
| |||||||||
Non-GAAP diluted EPS
|
$
|
0.60
|
$
|
0.51
|
$
|
1.68
|
$
|
1.24
| ||||||||
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
| ||||||||||||||||
Weighted average shares outstanding
| ||||||||||||||||
Basic
|
132,215
|
131,277
|
132,311
|
131,082
| ||||||||||||
Diluted
|
133,225
|
131,732
|
133,562
|
131,799
|
Reconciliation of GAAP to Non-GAAP Diluted EPS Guidance
| ||||||||
(unaudited)
| ||||||||
Three Months Ended
| ||||||||
March 31, 2022
| ||||||||
Low
|
High
| |||||||
GAAP Diluted EPS, guidance
|
$
|
0.13
|
$
|
0.27
| ||||
Adjustment to reconcile diluted EPS to non-GAAP diluted EPS:
| ||||||||
Stock-based compensation
|
0.15
|
0.15
| ||||||
Amortization of acquisition-related intangibles and fair value adjustments
|
0.10
|
0.10
| ||||||
Acquisition transaction and integration costs, restructuring charges and other
|
0.01
|
0.01
| ||||||
Net amortization of internally developed software costs
|
0.01
|
0.01
| ||||||
Income tax effects and adjustments(1) |
(0.05
|
)
|
(0.05
|
)
| ||||
Non-GAAP Diluted EPS, guidance
|
$
|
0.35
|
$
|
0.49
| ||||
(1): The income tax effect related to each non-GAAP item is calculated based on the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment, and considers the current and deferred tax impact of those adjustments.
|
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
National Instruments Corporation published this content on 27 January 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 January 2022 21:20:09 UTC.